MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 210 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,430,000 | -21.3% | 95,181 | -12.4% | 0.41% | -15.2% |
| Q2 2022 | $3,088,000 | -18.5% | 108,695 | +1.2% | 0.49% | -3.2% |
| Q1 2022 | $3,789,000 | -14.0% | 107,426 | +2.1% | 0.50% | -16.9% |
| Q4 2021 | $4,408,000 | +41.5% | 105,195 | +65.7% | 0.60% | +18.4% |
| Q3 2021 | $3,116,000 | +148.7% | 63,489 | +111.4% | 0.51% | +149.3% |
| Q2 2021 | $1,253,000 | +81.1% | 30,031 | +54.8% | 0.20% | +65.3% |
| Q1 2021 | $692,000 | – | 19,405 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |